ODTX
Odyssey Therapeutics, Inc.
Latest Form 4:Purchase$25.0MbyTPG GP A, LLC (Former 10% Owner) · filed May 13, 2026
Odyssey Therapeutics, Inc. (ODTX) has 9 SEC Form 4 filings (36 transaction rows) in the rolling window, disclosed by 7 distinct insiders. Most recent filing: May 13, 2026.
Insiders have net bought $75.3M over the trailing 6 months. The largest single insider purchase in this window was $25.0M by Insider TPG GP A, LLC on May 11, 2026.
- Industry:Biotechnology
- CEO:Gary D. Glick
- Employees:100
- HQ:Boston, MA, US
- IPO:2026-05-08
Insider Buying
$75.3M
reported purchases (SEC code P)
Insider Selling
$32K
reported sales (SEC code S)
Unique Insiders
7
in the rolling window
Market Cap
$1.0B
Price slightly stale
| Source | ||||||
|---|---|---|---|---|---|---|
| Former 10% Owner | Purchase | 1,388,889 | $25.0M | May 13 | SEC ↗ | |
Dimension Capital II, L.P.First filing | Director | Purchase | 1,111,111 | $20.0M | May 12 | SEC ↗ |
| 10% Owner | Sale | 1,780 | $32K | May 12 | SEC ↗ | |
| 10% Owner | Purchase | 555,555 | $10.0M | May 12 | SEC ↗ | |
LEIDEN JEFFREY MFirst in 5 months | Director | Purchase | 5,000 | $100K | May 12 | SEC ↗ |
Haas JasonFirst filing | Chief Financial Officer | Purchase | 1,000 | $20K | May 12 | SEC ↗ |
Li Nan (LN)First filing | Director | Purchase | 1,111,111 | $20.0M | May 12 | SEC ↗ |
Chu ShelleyFirst filing | Director | Purchase | 11,111 | $200K | May 12 | SEC ↗ |
Related companies
Odyssey Therapeutics, Inc. is in the Healthcare sector.